Your browser doesn't support javascript.
loading
Multimodal imaging shows fibrosis architecture and action potential dispersion are predictors of arrhythmic risk in spontaneous hypertensive rats.
Khwaounjoo, Prashanna; Sands, Gregory B; LeGrice, Ian J; Ramulgun, Girish; Ashton, Jesse L; Montgomery, Johanna M; Gillis, Anne M; Smaill, Bruce H; Trew, Mark L.
Afiliación
  • Khwaounjoo P; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Sands GB; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • LeGrice IJ; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Ramulgun G; Department of Physiology, University of Auckland, Auckland, New Zealand.
  • Ashton JL; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Montgomery JM; IHU-Liryc, University of Bordeaux, Bordeaux, France.
  • Gillis AM; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
  • Smaill BH; Department of Physiology, University of Auckland, Auckland, New Zealand.
  • Trew ML; Department of Physiology, University of Auckland, Auckland, New Zealand.
J Physiol ; 600(18): 4119-4135, 2022 09.
Article en En | MEDLINE | ID: mdl-35984854
ABSTRACT
Hypertensive heart disease (HHD) increases risk of ventricular tachycardia (VT) and ventricular fibrillation (VF). The roles of structural vs. electrophysiological remodelling and age vs. disease progression are not fully understood. This cross-sectional study of cardiac alterations through HHD investigates mechanistic contributions to VT/VF risk. Risk was electrically assessed in Langendorff-perfused, spontaneously hypertensive rat hearts at 6, 12 and 18 months, and paced optical membrane voltage maps were acquired from the left ventricular (LV) free wall epicardium. Distributions of LV patchy fibrosis and 3D cellular architecture in representative anterior LV mid-wall regions were quantified from macroscopic and microscopic fluorescence images of optically cleared tissue. Imaging showed increased fibrosis from 6 months, particularly in the inner LV free wall. Myocyte cross-section increased at 12 months, while inter-myocyte connections reduced markedly with fibrosis. Conduction velocity decreased from 12 months, especially transverse to the myofibre direction, with rate-dependent anisotropy at 12 and 18 months, but not earlier. Action potential duration (APD) increased when clustered by age, as did APD dispersion at 12 and 18 months. Among 10 structural, functional and age variables, the most reliably linked were VT/VF risk, general LV fibrosis, a measure quantifying patchy fibrosis, and non-age clustered APD dispersion. VT/VF risk related to a quantified measure of patchy fibrosis, but age did not factor strongly. The findings are consistent with the notion that VT/VF risk is associated with rate-dependent repolarization heterogeneity caused by structural remodelling and reduced lateral electrical coupling between LV myocytes, providing a substrate for heterogeneous intramural activation as HHD progresses. KEY POINTS There is heightened arrhythmic risk with progression of hypertensive heart disease. Risk is related to increasing left ventricular fibrosis, but the nature of this relationship has not been quantified. This study is a novel systematic characterization of changes in active electrical properties and fibrotic remodelling during progression of hypertensive heart disease in a well-established animal disease model. Arrhythmic risk is predicted by several left ventricular measures, in particular fibrosis quantity and structure, and epicardial action potential duration dispersion. Age alone is not a good predictor of risk. An improved understanding of links between arrhythmic risk and fibrotic architectures in progressive hypertensive heart disease aids better interpretation of late gadolinium-enhanced cardiac magnetic resonance imaging and electrical mapping signals.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Ventricular Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: J Physiol Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Ventricular Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: J Physiol Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda